Controversies in Perioperative Blood Management

Moderator(s)

• 

  Vicki Morton-Bailey, DNP, AGNP-BC

  Director, Clinical and Quality Outcomes
  Providence Anesthesiology Associates
  Charlotte, North Carolina, United States

  Disclosure(s): Edwards Lifescience: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Daniel Engelman, MD

  Medical Director, Heart & Vascular Critical Care Unit
  Baystate Medical Center
  Springfield, Massachusetts, United States

  Disclosure(s): Alexion: Advisory Board (Ongoing); Astellas Pharmaceuticals: Advisory Board (Ongoing); Edwards Life Science: DSMB (Ongoing); Guard Therapeutics: Drug trial steering committee (Ongoing); Medela: Advisory Board (Ongoing); Renibus: Drug Trial Steering committee (Ongoing); Rockwell Medical: Advisory Board (Ongoing); Terumo Medical Corporation: Advisory Board (Ongoing)

Presentations:

• 1:45 PM – 1:53 PM PT

  "Bloodless" Cardiac Surgery
  

  Rawn Salenger, MD – University of Maryland Saint Joseph Medical Center
• 1:53 PM – 2:01 PM PT

  Routine Preoperative Erythropoietin Stimulating Agents for Anemic Patients
  

  Thomas A. Schwann, MD, MBA – University of Massachussets-Baystate
• 2:01 PM – 2:09 PM PT

  Is Retained Blood Syndrome a Real Entity?
  

  Louis P. Perrault, MD, PhD, FRCSC, FACS, FECS (he/him/his) – Montreal Heart Institute, Université de Montréal
• 2:09 PM – 2:17 PM PT

  Setting up a Pre-Operative Anemia Clinic
  

  Brian Cho, MD – Johns Hopkins Medical Institute
• 2:17 PM – 2:27 PM PT

  Pre-existing Anemia and Risk of Adverse Outcomes in Cardiac Surgery Patients
  

  Motahar Hosseini – Mayo Clinic
• 2:27 PM – 2:45 PM PT

  Panel Discussion